Indoco Remedies Ltd. announced that its clinical research organisation, AnaCipher, located in Hyderabad, was inspected by the United States Food and Drug Administration (FDA) from September 12 to September 16, 2022. The clinical phase of inspection covered three BA/BE studies submitted by clients to the US FDA and was successfully concluded with zero 483s.
Indoco Remedies Ltd announced the receipt of GCP & GLP accreditation from the UK MHRA (Medicines and Healthcare Products Regulatory Agency) for its clinical research organisation - AnaCipher, located at Hyderabad for the virtual inspection carried out from 4th – 7th May and 10th - 11th May, 2021.